Presence and Relapse Rates in Patients With Alcohol Use Disorder Using Virtual Reality
Key facts
- Who runs it
- Charite University, Berlin, Germany
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 60 people enrolled
- Started
- 1 Apr 2024
- Ended
- 30 Mar 2025
- Type of study
- Observational, 2 groups
- Treatments tested
- VR Cue-Exposure Therapy
- Record updated
- 21 January 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (13)Hide the full registry criteria
Who can take part
- age: 18-65 years
- diagnosis of alcohol dependence according to ICD-10 (F10.2)
- completed in-patient withdrawal treatment during the last 3 months
- history of alcohol craving, confrmed via craving questionnaires
- able to provide written informed consent
Who cannot take part
- concurrent pharmacological treatment targeting AUD (i.e. benzodiazepines) or craving (i.e. acamprosate, disulfram, naltrexone, nalmefene)
- severe neuropsychiatric disorder, e.g., schizophrenia spectrum disorders, bipolar afective disorder or substantial cognitive impairment
- somatic diseases for which VR is associated with risks, e.g. photosensitive epilepsy
- substance dependence other than alcohol and nicotine
- current alcohol intoxication (randomly tested via measurement of breath alcohol concentration)
- unable to understand the study information, consent form or principles of the study
- abstinence for less than 7 days or on-going consumption of alcohol
- acute suicidality or acute endangerment of others
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Investigation of the influence of the sense of presence during a Virtual Reality Cue-Exposure Therapy (VR-CET) with alcohol-associated cues on craving and relapse rates.
Read full original descriptionShow less
Study group: abstinent patients (at least 18 years old) with a diagnosed alcohol dependence after completed inpatient withdrawal treatment in the the last 3 months.
Primary hypothesis: the experience of presence during a virtual presentation of alcohol in alcohol-dependent patients is associated with levels of craving for alcohol during VR-CET.
The 2 groups in the trial
- VR group
50 patients with diagnosed alcohol dependence (in-patients, patients in the outpatient department or day clinics) receiving VR Cue-Exposure Therapy (VR-CET) additional to the standard treatment.
Treatment: VR Cue-Exposure Therapy
- control group
50 patients with diagnosed alcohol dependence (in-patients, patients in the outpatient department or day clinics) receiving standard treatment.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 21 January 2026